Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billion in venture loans to thousands of companies. The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/5/2010
Ticker Symbol:
HRZN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2022 | Divergent | Private Equity Round | 0 |
6/2014 | Social Intelligence | Debt Financing | - |
1/2021 | Canary Medical | Debt Financing | 20M |
1/2021 | Alula Holdings | Debt Financing | 13M |
5/2020 | Magnolia Medical Technologies | Debt Financing | 20M |
1/2016 | Nomi | Debt Financing | 15M |
10/2015 | New Haven Pharmaceuticals | Debt Financing | 6.3M |
12/2021 | IMV Inc | Post-IPO Debt | 25M |
12/2013 | Mederi Therapeutics | Debt Financing | 10M |
7/2019 | OutboundEngine | Debt Financing | 8M |
2/2021 | Fingerlix | Series C | 0 |
6/2020 | Emalex Biosciences | Debt Financing | 15M |
2/2021 | Maverix Platforms | Series C | 0 |
7/2018 | New Signature | Debt Financing | 15M |
12/2014 | Interleukin Genetics | Post-IPO Debt | 5M |
10/2020 | Topia | Debt Financing | 15M |
4/2023 | Unagi Scooters | Debt Financing | 10M |
9/2014 | IntegenX | Debt Financing | 10M |
7/2018 | MacuLogix | Debt Financing | 10M |
3/2020 | Castle Creek Biosciences | Debt Financing | 20M |
11/2008 | Revance Therapeutics | Debt Financing | 0 |
6/2009 | Grab Media | Private Equity Round | 0 |
11/2021 | Everstream Analytics | Debt Financing | 5M |
5/2015 | SilkRoad Technology | Debt Financing | 7.5M |
10/2014 | InVisage Technologies | Debt Financing | - |
7/2022 | Divergent | Debt Financing | 80M |
7/2022 | Nexii | Venture Round | 34.5M |
12/2017 | Aerin Medical | Debt Financing | 15M |
11/2020 | Getaround | Debt Financing | 25M |
10/2022 | Kodiak Robotics | Debt Financing | 30M |
6/2021 | Cerecor | Post-IPO Debt | 20M |
7/2017 | PebblePost | Series B | 15M |
6/2018 | Ontrak | Post-IPO Debt | 10M |
4/2017 | IgnitionOne | Debt Financing | 12M |
8/2016 | Receptiv | Venture Round | 6.5M |
11/2007 | Ambit Biosciences | Series D | 49.3M |
5/2019 | Meditrina, Inc | Debt Financing | 5M |
7/2014 | Mblox | Debt Financing | 43.5M |
7/2022 | INBRACE | Debt Financing | 0 |
9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
12/2020 | IDbyDNA | Debt Financing | 10M |
8/2021 | Cerecor | Post-IPO Debt | 10M |
8/2021 | Nogin | Debt Financing | 15M |
5/2015 | SavingStar | Debt Financing | 5M |
5/2020 | Ceribell | Debt Financing | 20M |
3/2016 | Avalanche Technology | Debt Financing | - |
8/2012 | Valore | Debt Financing | 5M |
2/2015 | NinePoint Medical | Debt Financing | 15M |
12/2014 | Palatin Technologies | Post-IPO Debt | 10M |
1/2018 | IntelePeer | Debt Financing | 15M |
4/2015 | ScoreBig | Debt Financing | 7M |
4/2019 | Mustang Bio | Post-IPO Debt | 20M |
11/2020 | Sonex Health | Debt Financing | 7.5M |
9/2014 | Argos Therapeutics | Post-IPO Debt | 25M |
6/2013 | Overture Networks | Debt Financing | 10M |
3/2016 | ScoreBig | Debt Financing | 2M |
10/2022 | Robin Healthcare | Debt Financing | 7M |
12/2016 | Strongbridge Biopharma | Post-IPO Debt | 40M |
7/2014 | SpringCM | Debt Financing | 6M |
3/2022 | Secure Transfusion Services | Debt Financing | 15M |
3/2010 | Enphase Energy | Venture Round | 0 |
5/2022 | Soli Organic | Debt Financing | 0 |
7/2017 | Titan Pharmaceuticals | Post-IPO Debt | 10M |
6/2015 | Medsphere Systems | Debt Financing | 7.5M |
7/2021 | RepTrak | Debt Financing | 10M |
7/2015 | Bridge2 Solutions | Debt Financing | 5M |
8/2021 | Embody | Venture Round | 11.5M |
3/2022 | Aerobiotix | Debt Financing | 10M |
10/2021 | Stealth BioTherapeutics | Post-IPO Debt | 25M |
7/2019 | Evelo | Post-IPO Debt | 45M |
6/2021 | LiquiGlide | Debt Financing | 8M |
8/2021 | Embody | Debt Financing | 9M |
8/2022 | PDS Biotechnology Corporation | Post-IPO Debt | 25M |
1/2016 | Digital Signal | Debt Financing | 12M |
4/2005 | Intarcia Therapeutics | Debt Financing | 10M |
1/2022 | Interior Define | Debt Financing | 30M |
12/2020 | Corinth MedTech | Debt Financing | 5M |
12/2008 | Tagged | Debt | 5M |
2/2014 | AccuVein | Debt Financing | 8M |
6/2014 | GenePeeks | Debt Financing | 3M |
3/2006 | Copan Systems | Series C | 17.5M |
6/2018 | Audacy | Debt Financing | 4M |
4/2019 | Encore Dermatology | Debt Financing | 20M |
3/2012 | Radisphere Radiology | Debt Financing | 15M |
12/2022 | Slingshot Aerospace | Debt Financing | - |
2/2019 | CSA Medical | Venture Round | 45.2M |
6/2018 | Audacy | Debt Financing | 4M |
10/2014 | ZetrOZ | Debt Financing | 5M |
1/2018 | Conventus Orthopaedics | Debt Financing | 12M |
7/2022 | Nexii | Venture Round | 0 |
7/2022 | INBRACE | Debt Financing | 0 |
7/2022 | Divergent | Private Equity Round | 0 |
5/2022 | Soli Organic | Debt Financing | 0 |
3/2022 | Secure Transfusion Services | Debt Financing | 0 |
3/2022 | Aerobiotix | Debt Financing | 0 |
1/2022 | Interior Define | Debt Financing | 0 |
12/2021 | IMV Inc | Post-IPO Debt | 0 |
11/2021 | Everstream Analytics | Debt Financing | 0 |
10/2021 | Stealth BioTherapeutics | Post-IPO Debt | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|